139 related articles for article (PubMed ID: 29629675)
1. The current aetiology of malignant pleural effusion in the Western Cape Province, South Africa.
Koegelenberg CFN; Bennji SM; Boer E; Schubert PT; Shaw JA; Allwood BW; Irusen EM
S Afr Med J; 2018 Mar; 108(4):275-277. PubMed ID: 29629675
[TBL] [Abstract][Full Text] [Related]
2. Talc pleurodesis as surgical palliation of patients with malignant pleural effusion. Analysis of factors affecting survival.
Lumachi F; Mazza F; Ermani M; Chiara GB; Basso SM
Anticancer Res; 2012 Nov; 32(11):5071-4. PubMed ID: 23155281
[TBL] [Abstract][Full Text] [Related]
3. Palliative treatment of malignant pleural effusions by video-assisted thoracoscopic surgery.
Benkó I; Molnár TF; Horváth OP
Acta Chir Hung; 1999; 38(2):131-3. PubMed ID: 10596313
[TBL] [Abstract][Full Text] [Related]
4. Bedside talc pleurodesis for malignant pleural effusion: factors affecting success.
Aydogmus U; Ozdemir S; Cansever L; Sonmezoglu Y; Kocaturk CI; Bedirhan MA
Ann Surg Oncol; 2009 Mar; 16(3):745-50. PubMed ID: 19116753
[TBL] [Abstract][Full Text] [Related]
5. Improved quality of life in patients with malignant pleural effusion following videoassisted thoracoscopic talc pleurodesis. Preliminary results.
Basso SM; Mazza F; Marzano B; Santeufemia DA; Chiara GB; Lumachi F
Anticancer Res; 2012 Nov; 32(11):5131-4. PubMed ID: 23155293
[TBL] [Abstract][Full Text] [Related]
6. Interventional therapies for malignant pleural effusions: the present and the future.
Thomas R; Francis R; Davies HE; Lee YC
Respirology; 2014 Aug; 19(6):809-22. PubMed ID: 24947955
[TBL] [Abstract][Full Text] [Related]
7. The significance of thoracoscopic mechanical pleurodesis for the treatment of malignant pleural effusions.
Crnjac A
Wien Klin Wochenschr; 2004; 116 Suppl 2():28-32. PubMed ID: 15506307
[TBL] [Abstract][Full Text] [Related]
8. Is Systemic Anticancer Therapy Associated With Higher Rates of Malignant Pleural Effusion Control in People With Pharmacologically Sensitive Tumors?: A Retrospective Analysis of Prospectively Collected Data.
Holling N; Patole S; Medford ARL; Maskell NA; Bibby AC
Chest; 2021 Nov; 160(5):1915-1924. PubMed ID: 34023321
[TBL] [Abstract][Full Text] [Related]
9. ERS/EACTS statement on the management of malignant pleural effusions.
Bibby AC; Dorn P; Psallidas I; Porcel JM; Janssen J; Froudarakis M; Subotic D; Astoul P; Licht P; Schmid R; Scherpereel A; Rahman NM; Cardillo G; Maskell NA
Eur Respir J; 2018 Jul; 52(1):. PubMed ID: 30054348
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of malignant pleural effusion by pleurodesis with talc].
Filippetti M; Crucitti G; Vanni B; Della Giulia M; Foggi P; Del Monte G
Chir Ital; 2000; 52(5):541-7. PubMed ID: 11190547
[TBL] [Abstract][Full Text] [Related]
11. Intrapleural staphylococcal superantigen induces resolution of malignant pleural effusions and a survival benefit in non-small cell lung cancer.
Ren S; Terman DS; Bohach G; Silvers A; Hansen C; Colt H; Sahn SA
Chest; 2004 Nov; 126(5):1529-39. PubMed ID: 15539723
[TBL] [Abstract][Full Text] [Related]
12. Impact of pleural effusion pH on the efficacy of thoracoscopic mechanical pleurodesis in patients with breast carcinoma.
Crnjac A; Sok M; Kamenik M
Eur J Cardiothorac Surg; 2004 Aug; 26(2):432-6. PubMed ID: 15296910
[TBL] [Abstract][Full Text] [Related]
13. [Videothoracoscopic collagen pleurodesis in malignant pleural effusion].
Akopov AL; Varlamov VV; Egorov VI; Kondrat'ev VB; Pukhova ZI
Ter Arkh; 2004; 76(3):51-4. PubMed ID: 15108460
[TBL] [Abstract][Full Text] [Related]
14. Outcome and characteristics of patients with malignant pleural effusion from differentiated thyroid carcinoma.
Tomoda C; Ogimi Y; Saito F; Masaki C; Akaishi J; Matsuzu K; Suzuki A; Uruno T; Ohkuwa K; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K
Endocr J; 2016; 63(3):257-61. PubMed ID: 26655349
[TBL] [Abstract][Full Text] [Related]
15. Talc pleurodesis improves survival of patients with malignant pleural effusions: case-control study.
Korsic M; Badovinac S; Cucevic B; Janevski Z
Wien Klin Wochenschr; 2015 Dec; 127(23-24):963-9. PubMed ID: 25860847
[TBL] [Abstract][Full Text] [Related]
16. Clinical efficacy and safety of thoracoscopic talc pleurodesis in malignant pleural effusions.
Kolschmann S; Ballin A; Gillissen A
Chest; 2005 Sep; 128(3):1431-5. PubMed ID: 16162739
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and management of malignant pleural effusions.
Heffner JE
Respirology; 2008 Jan; 13(1):5-20. PubMed ID: 18197908
[TBL] [Abstract][Full Text] [Related]
18. Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion.
Fysh ETH; Waterer GW; Kendall PA; Bremner PR; Dina S; Geelhoed E; McCarney K; Morey S; Millward M; Musk AWB; Lee YCG
Chest; 2012 Aug; 142(2):394-400. PubMed ID: 22406960
[TBL] [Abstract][Full Text] [Related]
19. Talc poudrage versus talc slurry in the treatment of malignant pleural effusion. A prospective comparative study.
Stefani A; Natali P; Casali C; Morandi U
Eur J Cardiothorac Surg; 2006 Dec; 30(6):827-32. PubMed ID: 17113008
[TBL] [Abstract][Full Text] [Related]
20. Predictors of talc pleurodesis outcome in patients with malignant pleural effusions.
Yildirim H; Metintas M; Ak G; Metintas S; Erginel S
Lung Cancer; 2008 Oct; 62(1):139-44. PubMed ID: 18403045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
